Australia - English - Department of Health (Therapeutic Goods Administration)

sphere healthcare pty ltd - cod-liver oil, quantity: 500 mg (equivalent: retinol, qty 300 iu; equivalent: colecalciferol, qty 30 iu) - capsule, soft - excipient ingredients: gelatin; glycerol; purified water - nutritional supplement.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline consumer healthcare sdn. bhd. - cod liver oil -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer australia ltd (animal health) - cod liver oil | paraffin-soft white | paraffin - liquid - alimentary system - cat | cat - queen | cat - tom | kitten - laxative, purgative or lubricant | appetite | bloated | bowels | constipation | constitution | diuretic | hairball removal | impaction | indigestion | ingested hair | laxatives | lubricants | pre-operative | purgative | rumenal atony | rumenal stimulant

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hovid pharmacy sdn. bhd. - cod liver oil -

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - cod liver oil, zinc oxide - ointment - 11.4/38 %w/w - cod-liver oil ointments

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - yellow beeswax; paraffin-soft white; malt syrup; lecithin; caramel; cod liver oil; biotin - vitamin h - oral paste - yellow beeswax ungrouped active 2.1 g/tbe; paraffin-soft white petroleum derivative-filler active 31.1 g/tbe; malt syrup food-plant other 33.2 g/tbe; lecithin amino zwitterion other 1.4 g/tbe; caramel food-flavour other 0.422 g/tbe; cod liver oil oil-animal extract other 1.134 g/tbe; biotin - vitamin h vitamin-b complex other 0.0056 g/tbe - alimentary system - cat | cat - queen | cat - tom | kitten - laxative, purgative or lubricant | appetite | bloated | bowels | constipation | constitution | diuretic | hairball removal | impaction | indigestion | ingested hair | laxatives | lubricants | pre-operative | purgative | rumenal atony | rumenal stimulant

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - neomycin sulfate; chlorophyll; nitrofurazone; cod liver oil; prednisolone - topical cream, ointment, paste, gel, lotion - neomycin sulfate antibiotic active 5.0 mg/g; chlorophyll extract-plant active 20.0 mg/g; nitrofurazone nitrofuran active 2.0 mg/g; cod liver oil oil-animal extract active 100.0 mg/g; prednisolone steroid-glucocorticoid active 2.5 mg/g - dermatological preps. - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - antibiotic - anti-infective | anti-inflammatory agent | antimycotic | eczema | oedema | skin irritation | wound dressing | abrasions | abscesses | airsacculitis | antifungal | antipyretic | antiseptic | avian mycoplasmas | blackhead | body odours | bone soreness | bowed tendons | broad spectrum | bruising | burns | bursitis | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | feed efficiency | fungal infections | girth galls | infections | inflammatory rheumatic arthrit | inflammed pads | itching | joint disease | keratolytic | lacerations | ligament sprains | mastitis | muscle soreness | mycoplasmas | odours | open wounds | osteoarthritis | otitis | physiological of the mammary g | platelet activity | poultice dressing | pruritis | queensland itch | respiratory disease | rheumatism | saddle rash | salmonellosis | scabs | scaly skin | sheath rot |

Australia - English - Department of Health (Therapeutic Goods Administration)

nature's family australia pty ltd - concentrated fish omega-3 triglycerides,cod-liver oil,d-alpha-tocopherol -

United States - English - NLM (National Library of Medicine)

par pharmaceutical - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570) - oxycodone hydrochloride 10 mg - oxycodone hydrochloride tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1)] , reserve oxycodone hydrochloride tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products): - have not been tolerated or are not expected to be tolerated, - have not provided adequate analgesia or are not expected to provide adequate analgesia. oxycodone hydrochloride tablets are contraindicated in patients with: - significant respiratory depression [see warnings and precautions (5.3)] -   acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment or hypercarbia [see warnings and precautions (5.7)] -   known or suspected gastrointestinal obstruction, including paralytic ileus

United States - English - NLM (National Library of Medicine)

redpharm drug, inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 5 mg - oxycodone and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve oxycodone and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] have not been tolerated, or are not expected to be tolerated, have not provided adequate analgesia, or are not expected to provide adequate analgesia oxycodone and acetaminophen tablets are contraindicated in patients with: significant respiratory depression [see warnings ] acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings ] hypersensitivity to oxycodone, acetaminophen, or any other component of the pr